SUSMED, Inc.
4263.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | ¥10,260 | ¥9,098 | ¥8,939 | ¥8,002 |
| - Cash | ¥4,398 | ¥4,847 | ¥5,049 | ¥4,904 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥5,862 | ¥4,251 | ¥3,890 | ¥3,098 |
| Revenue | ¥463 | ¥343 | ¥531 | ¥317 |
| % Growth | 35.1% | -35.4% | 67.5% | – |
| Gross Profit | ¥451 | ¥331 | ¥523 | ¥306 |
| % Margin | 97.4% | 96.6% | 98.5% | 96.7% |
| EBITDA | -¥289 | -¥359 | -¥44 | -¥228 |
| % Margin | -62.5% | -104.8% | -8.3% | -72% |
| Net Income | -¥298 | -¥357 | -¥51 | -¥233 |
| % Margin | -64.5% | -104.3% | -9.6% | -73.7% |
| EPS Diluted | -17.77 | -21.41 | -3.09 | -15.9 |
| % Growth | 17% | -592.9% | 80.6% | – |
| Operating Cash Flow | -¥432 | -¥231 | ¥101 | -¥165 |
| Capital Expenditures | -¥4 | -¥9 | -¥18 | -¥13 |
| Free Cash Flow | -¥437 | -¥240 | ¥82 | -¥178 |